ILIAS Biologics
- Biotech or pharma, therapeutic R&D
ILIAS Biologics is a clinical-stage biotech specializing in the development of exosome therapeutics. Our company boasts a platform technology capable of delivering a wide range of therapeutic modalities targeting intracellular key signaling pathways.
We will be presenting our latest progress and partnering opportunities during our company presentation on Monday, June 16 at 5:00 PM in Room 153C. We look forward to connecting with potential partners and collaborators at the event.



